Milrinone Lactate in Dextrose (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Milrinone Lactate in Dextrose drug offered from Baxter Healthcare Corporation. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | MILRINONE LACTATE |
SUBSTANCE NAME: | MILRINONE LACTATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2002-05-28 |
END MARKETING DATE: | 0000-00-00 |
Milrinone Lactate in Dextrose HUMAN PRESCRIPTION DRUG Details:
Item Description | Milrinone Lactate in Dextrose from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.2(mg/mL) |
START MARKETING DATE: | 2002-05-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-6010_9ece85fc-d06c-40fb-a521-4c2690f03b86 |
PRODUCT NDC: | 0338-6010 |
APPLICATION NUMBER: | ANDA075834 |
Other MILRINONE LACTATE Pharmaceutical Manufacturers / Labelers: